Source: Hepatology. Unidade: FM
Subjects: HEPATITE B (IMUNOLOGIA), HEPATITE CRÔNICA (TERAPIA), ANTÍGENOS, NEOPLASIAS HEPÁTICAS, CARCINOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHANG, Ting-Tsung et al. Entecavir treatment for up to 5 years in patients with hepatitis b e antigen-positive chronic hepatitis B. Hepatology, v. 51, n. 2, p. 422-430, 2010Tradução . . Disponível em: https://doi.org/10.1002/hep.23327. Acesso em: 18 out. 2024.APA
Chang, T. -T., Lai, C. -L., Yoon, S. K., Lee, S. S., Coelho, H. S. M., Carrilho, F. J., et al. (2010). Entecavir treatment for up to 5 years in patients with hepatitis b e antigen-positive chronic hepatitis B. Hepatology, 51( 2), 422-430. doi:10.1002/hep.23327NLM
Chang T-T, Lai C-L, Yoon SK, Lee SS, Coelho HSM, Carrilho FJ, Halota W, Horsmans Y, Tsai N, Zhang H, Tenney DJ, Tamez R, Hoeje U. Entecavir treatment for up to 5 years in patients with hepatitis b e antigen-positive chronic hepatitis B [Internet]. Hepatology. 2010 ; 51( 2): 422-430.[citado 2024 out. 18 ] Available from: https://doi.org/10.1002/hep.23327Vancouver
Chang T-T, Lai C-L, Yoon SK, Lee SS, Coelho HSM, Carrilho FJ, Halota W, Horsmans Y, Tsai N, Zhang H, Tenney DJ, Tamez R, Hoeje U. Entecavir treatment for up to 5 years in patients with hepatitis b e antigen-positive chronic hepatitis B [Internet]. Hepatology. 2010 ; 51( 2): 422-430.[citado 2024 out. 18 ] Available from: https://doi.org/10.1002/hep.23327